- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CHORDATE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.12. | Chordate Medical Holding AB: Chordate Medical terminates the liquidity guarantee for the common share | 119 | GlobeNewswire (Europe) | Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the common share CMH.
The purpose of the liquidity... ► Artikel lesen | |
| 08.12. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 78 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on December 8, 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals... ► Artikel lesen | |
| 19.11. | Chordate Medical Holding AB (publ) receives observation status | 120 | GlobeNewswire | Yesterday, November 18, 2025, Chordate Medical Holding AB (publ) (the "Company") disclosed a notice convening an extraordinary general meeting of the Company's shareholders, with a proposal for voluntary... ► Artikel lesen | |
| 21.08. | Chordate Medical Holding AB: Chordate Announces Cost Reduction and Focus on Company Sale | 145 | GlobeNewswire (Europe) | Chordate Medical Holding AB (Publ.) (the "Company") has adopted a cost reduction program that includes focusing activities on the continued ambition to sell the Company. Together with the recently completed... ► Artikel lesen | |
| 19.08. | Chordate Medical Holding AB: Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010 | 179 | GlobeNewswire (Europe) | Since this Post Market Surveillance study is open-label (uncontrolled), it is possible - and the sponsor's responsibility - to actively monitor study data during the ongoing trial. It is both scientifically... ► Artikel lesen | |
| 17.07. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 263 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on 17 July 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals previously... ► Artikel lesen | |
| 23.05. | Chordate Medical Holding AB: Chordate Medical Holding AB (publ) Interim Report January-March 2025 | 210 | GlobeNewswire (Europe) | Summary of the period January-March 2025Net turnover was SEK 596,105 (257,677)Cash flow from operating activities was SEK -6,046,406 (-5,908,058)Profit/loss after financial items was SEK -5,756,609... ► Artikel lesen | |
| 28.03. | Chordate Medical Holding AB: Year-End Report Chordate Medical Holding AB (publ) January - December 2024 | 243 | GlobeNewswire (Europe) | Summary of the period October-December 2024Net turnover was SEK 86,076 (481,597)Cash flow from operating activities was SEK -4,659,856 (-7,501,648)Profit/loss after financial items was SEK -8,529,829... ► Artikel lesen | |
| 31.01. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Chordate Medical Holding AB (publ) | 309 | GlobeNewswire | With effect from February 03, 2025, the unit rights in Chordate Medical Holding AB (publ) will be traded on First North Growth Market. Trading will continue up until and including February 12, 2025.
Instrument:
Unit... ► Artikel lesen | |
| 29.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.01.2025 | 736 | Xetra Newsboard | Das Instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY wird ex Kapitalmassnahme gehandelt am 29.01.2025 The instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY is traded ex capital... ► Artikel lesen | |
| 28.01. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 228 | GlobeNewswire (Europe) | The following resolutions was adopted at the extraordinary general meeting of Chordate Medical Holding AB (publ) held on 28 January 2025
Amendment of the articles of associationThe general meeting resolved... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ATRICURE | 40,330 | -0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.09.2025 | The following instruments on XETRA do have their first trading 18.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.09.2025
Aktien
1 US64119N6085 Netskope Inc.
2 IE00BFY8C754... ► Artikel lesen | |
| GENEDX | 134,29 | -1,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| RXSIGHT | 10,930 | -4,62 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| PACS GROUP | 38,090 | +2,26 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NUTEX HEALTH | 176,68 | +5,10 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| ADAPTHEALTH | 10,240 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| CERIBELL | 21,300 | -0,56 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| BETA BIONICS | 31,860 | +2,48 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |
CHORDATE MEDICAL HOLDING AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,072 Euro und damit -16,40 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHORDATE MEDICAL HOLDING AB finden Sie auf Wallstreet Online.